Global Specimen Validity Testing Market By Product Type (Laboratory Testing, Rapid/POC Testing) And By End-Users/Application (Workplaces, Drug Screening Laboratories) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Specimen Validity Testing market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Specimen Validity Testing market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Specimen Validity Testing industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Specimen Validity Testing ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Specimen Validity Testing market.

The following manufacturers are covered in this report:
  • Thermo Fisher (US)
  • Sciteck. (US)
  • American Bio Medica Corporation (ABMC)
  • Alere (US)
  • Express Diagnostics (US)
  • Premier Biotech (US)
  • LabCorp (US)
  • Quest Diagnostics (US)
  • Alere Toxicology (US)
  • ACM Global Laboratories (US)
  • Clinical Reference Laboratory (CRL) (US)
  • SureHire (Canada)
  • CannAmm (Canada)

The report estimates on the Specimen Validity Testing market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Specimen Validity Testing market report consist of all leading industry players, Specimen Validity Testing business sections, company profile, revenue supply by Specimen Validity Testing industry sections, global Specimen Validity Testing market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Specimen Validity Testing market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Specimen Validity Testing market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Specimen Validity Testing market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Specimen Validity Testing market.

Report Opportunity: Global Specimen Validity Testing Market

This report delivers an analytical examination of the Specimen Validity Testing market summarized in broad sections such as
  1. Specimen Validity Testing Market Summary
  2. Key Commercial Growths in the Specimen Validity Testing Industry
  3. Market Dynamics Affecting the Specimen Validity Testing Industry
  4. Important Market Trends and Future Development Scenario of the Specimen Validity Testing Market
  5. Specimen Validity Testing Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Specimen Validity Testing Industry
  7. Positioning of Main Market Players in the Specimen Validity Testing Industry
  8. Specimen Validity Testing Market Revenue and Forecast, by Application, 2018 - 2028
  9. Specimen Validity Testing Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Specimen Validity Testing Market Revenue and Forecast, by Geography, 2018 - 2028
Specimen Validity Testing Market Segmentation:

The report provides detailed examination of the Specimen Validity Testing market on the basis of various segments such as type, application and end-use industry. The Specimen Validity Testing market is segmented as follows:

Specimen Validity Testing Market, by Type:
  • Laboratory Testing
  • Rapid/POC Testing
Specimen Validity Testing Market, by Application:
  • Workplaces
  • Drug Screening Laboratories
  • Criminal Justice and Law Enforcement Agencies
  • Pain Management Centers
  • Drug Rehabilitation Centers
  • Others
Geographic Coverage

The report on the Specimen Validity Testing market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Specimen Validity Testing Market Revenue and Forecast
  • U.S.
  • Canada
Europe Specimen Validity Testing Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Specimen Validity Testing Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Specimen Validity Testing Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Specimen Validity Testing Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Specimen Validity Testing Market Snapshot
          2.1.1. Global Specimen Validity Testing Market By Type,2019
               2.1.1.1.Laboratory Testing
               2.1.1.2.Rapid/POC Testing
          2.1.2. Global Specimen Validity Testing Market By Application,2019
               2.1.2.1.Workplaces
               2.1.2.2.Drug Screening Laboratories
               2.1.2.3.Criminal Justice and Law Enforcement Agencies
               2.1.2.4.Pain Management Centers
               2.1.2.5.Drug Rehabilitation Centers
               2.1.2.6.Others
          2.1.3. Global Specimen Validity Testing Market By End-use,2019
          2.1.4. Global Specimen Validity Testing Market By Geography,2019

3. Global Specimen Validity Testing Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Specimen Validity Testing Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Specimen Validity Testing Market Size (US$), By Type, 2018 – 2028

5. Global Specimen Validity Testing Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Specimen Validity Testing Market Size (US$), By Application, 2018 – 2028

6. Global Specimen Validity Testing Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Specimen Validity Testing Market Size (US$), By End-use, 2018 – 2028

7. Global Specimen Validity Testing Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Specimen Validity Testing Market Analysis, 2018 – 2028 
          7.2.1. North America Specimen Validity Testing Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Specimen Validity Testing Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Specimen Validity Testing Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Specimen Validity Testing Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Specimen Validity Testing Market Analysis, 2018 – 2028 
          7.3.1.  Europe Specimen Validity Testing Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Specimen Validity Testing Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Specimen Validity Testing Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Specimen Validity Testing Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Specimen Validity Testing Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Specimen Validity Testing Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Specimen Validity Testing Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Specimen Validity Testing Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Specimen Validity Testing Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Specimen Validity Testing Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Specimen Validity Testing Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Specimen Validity Testing Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Specimen Validity Testing Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Specimen Validity Testing Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Specimen Validity Testing Market Analysis, 2018 – 2028 
          7.6.1.  MEA Specimen Validity Testing Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Specimen Validity Testing Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Specimen Validity Testing Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Specimen Validity Testing Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Specimen Validity Testing Providers
        8.4.1 Thermo Fisher (US)
                8.1.1 Business Description
                8.1.2 Thermo Fisher (US) Geographic Operations
                8.1.3 Thermo Fisher (US) Financial Information
                8.1.4 Thermo Fisher (US) Product Positions/Portfolio
                8.1.5 Thermo Fisher (US) Key Developments
        8.4.2 Sciteck. (US)
                8.2.1 Business Description
                8.2.2 Sciteck. (US) Geographic Operations
                8.2.3 Sciteck. (US) Financial Information
                8.2.4 Sciteck. (US) Product Positions/Portfolio
                8.2.5 Sciteck. (US) Key Developments
        8.4.3 American Bio Medica Corporation (ABMC)
                8.3.1 Business Description
                8.3.2 American Bio Medica Corporation (ABMC) Geographic Operations
                8.3.3 American Bio Medica Corporation (ABMC) Financial Information
                8.3.4 American Bio Medica Corporation (ABMC) Product Positions/Portfolio
                8.3.5 American Bio Medica Corporation (ABMC) Key Developments
        8.4.4 Alere (US)
                8.4.1 Business Description
                8.4.2 Alere (US) Geographic Operations
                8.4.3 Alere (US) Financial Information
                8.4.4 Alere (US) Product Positions/Portfolio
                8.4.5 Alere (US) Key Developments
        8.4.5 Express Diagnostics (US)
                8.5.1 Business Description
                8.5.2 Express Diagnostics (US) Geographic Operations
                8.5.3 Express Diagnostics (US) Financial Information
                8.5.4 Express Diagnostics (US) Product Positions/Portfolio
                8.5.5 Express Diagnostics (US) Key Developments
        8.4.6 Premier Biotech (US)
                8.6.1 Business Description
                8.6.2 Premier Biotech (US) Geographic Operations
                8.6.3 Premier Biotech (US) Financial Information
                8.6.4 Premier Biotech (US) Product Positions/Portfolio
                8.6.5 Premier Biotech (US) Key Developments
        8.4.7 LabCorp (US)
                8.7.1 Business Description
                8.7.2 LabCorp (US) Geographic Operations
                8.7.3 LabCorp (US) Financial Information
                8.7.4 LabCorp (US) Product Positions/Portfolio
                8.7.5 LabCorp (US) Key Developments
        8.4.8 Quest Diagnostics (US)
                8.8.1 Business Description
                8.8.2 Quest Diagnostics (US) Geographic Operations
                8.8.3 Quest Diagnostics (US) Financial Information
                8.8.4 Quest Diagnostics (US) Product Positions/Portfolio
                8.8.5 Quest Diagnostics (US) Key Developments
        8.4.9 Alere Toxicology (US)
                8.9.1 Business Description
                8.9.2 Alere Toxicology (US) Geographic Operations
                8.9.3 Alere Toxicology (US) Financial Information
                8.9.4 Alere Toxicology (US) Product Positions/Portfolio
                8.9.5 Alere Toxicology (US) Key Developments
        8.4.10 ACM Global Laboratories (US)
                8.10.1 Business Description
                8.10.2 ACM Global Laboratories (US) Geographic Operations
                8.10.3 ACM Global Laboratories (US) Financial Information
                8.10.4 ACM Global Laboratories (US) Product Positions/Portfolio
                8.10.5 ACM Global Laboratories (US) Key Developments
        8.4.11 Clinical Reference Laboratory (CRL) (US)
                8.11.1 Business Description
                8.11.2 Clinical Reference Laboratory (CRL) (US) Geographic Operations
                8.11.3 Clinical Reference Laboratory (CRL) (US) Financial Information
                8.11.4 Clinical Reference Laboratory (CRL) (US) Product Positions/Portfolio
                8.11.5 Clinical Reference Laboratory (CRL) (US) Key Developments
        8.4.12 SureHire (Canada)
                8.12.1 Business Description
                8.12.2 SureHire (Canada) Geographic Operations
                8.12.3 SureHire (Canada) Financial Information
                8.12.4 SureHire (Canada) Product Positions/Portfolio
                8.12.5 SureHire (Canada) Key Developments
        8.4.13 CannAmm (Canada)
                8.13.1 Business Description
                8.13.2 CannAmm (Canada) Geographic Operations
                8.13.3 CannAmm (Canada) Financial Information
                8.13.4 CannAmm (Canada) Product Positions/Portfolio
                8.13.5 CannAmm (Canada) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Specimen Validity Testing Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Specimen Validity Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Specimen Validity Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Specimen Validity Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Specimen Validity Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Specimen Validity Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Specimen Validity Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Specimen Validity Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Specimen Validity Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Specimen Validity Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Specimen Validity Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Specimen Validity Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Specimen Validity Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Specimen Validity Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Specimen Validity Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Specimen Validity Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Specimen Validity Testing: Market Segmentation 
FIG. 2 Global Specimen Validity Testing Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Specimen Validity Testing Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Specimen Validity Testing Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Specimen Validity Testing Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Specimen Validity Testing Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Specimen Validity Testing Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Specimen Validity Testing Providers, 2019
FIG. 11 Global Specimen Validity Testing Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Specimen Validity Testing Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Specimen Validity Testing Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Specimen Validity Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Specimen Validity Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Specimen Validity Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Specimen Validity Testing Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Specimen Validity Testing Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Specimen Validity Testing market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
7826

1732

OUR CLIENT